Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies User HealthEconBot, in the Health Economics Journal Articles subreddit, 13 Jun 2017